Skip to content
OpenCapital
Get started

Organon OGN Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies

PBH
Prestige Consumer HealthcarePBH
——
Viatris logo
ViatrisVTRS
——
Merck & Co. logo
Merck & Co.MRK
——

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Organon (OGN) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $26.31 in Q1 2026.
How has Organon's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
Organon's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 3.5% year-over-year, from $25.42 to $26.31.
What is the long-term trend for Organon's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
Over 4 years (2021 to 2025), Organon's share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a -5.6% compound annual growth rate (CAGR), from $34.35 to $27.3.